9/16/2022 12:19:45 PM - Consolidating near its 50 DMA line ($72.14) following noted volume-driven gains. Reported Jul &#39;22 quarterly earnings +30% on +11% sales revenues versus the year ago period. Fundamental concerns remain as prior quarterly and annual earnings (C and A criteria) are not a match with the fact-based investment system&#39;s guidelines.<br><hr>9/15/2022 12:41:29 PM - Consolidating above its 50 DMA line ($72.06) following volume-driven gains. Reported Jul &#39;22 quarterly earnings +30% on +11% sales revenues versus the year ago period. Fundamental concerns remain as prior quarterly and annual earnings (C and A criteria) are not a match with the fact-based investment system&#39;s guidelines.<br><hr>9/14/2022 12:27:35 PM - Consolidating above its 50 DMA line ($71.97) following volume-driven gains. Reported Jul &#39;22 quarterly earnings +30% on +11% sales revenues versus the year ago period. Fundamental concerns remain as prior quarterly and annual earnings (C and A criteria) are not a match with the fact-based investment system&#39;s guidelines.<br><hr>9/12/2022 12:23:59 PM - Rising further above its 50 DMA line ($71.80) with today&#39;s 4th consecutive volume-driven gain. Reported Jul &#39;22 quarterly earnings +30% on +11% sales revenues versus the year ago period. Fundamental concerns remain as prior quarterly and annual earnings (C and A criteria) are not a match with the fact-based investment system&#39;s guidelines.<br><hr>9/9/2022 12:23:40 PM - Consolidating above its 50 DMA line ($71.69) with today&#39;s 3rd consecutive volume-driven gain after briefly undercutting the 50 DMA line with recent volume-driven losses. Reported Jul &#39;22 quarterly earnings +30% on +11% sales revenues versus the year ago period. Fundamental concerns remain as prior quarterly and annual earnings (C and A criteria) are not a match with the fact-based investment system&#39;s guidelines.<br><hr>9/8/2022 12:29:12 PM - Consolidating near its 50 DMA line ($71.57) following volume-driven losses. Reported Jul &#39;22 quarterly earnings +30% on +11% sales revenues versus the year ago period. Fundamental concerns remain as prior quarterly and annual earnings (C and A criteria) are not a match with the fact-based investment system&#39;s guidelines.<br><hr>9/7/2022 12:14:20 PM - Still consolidating below its 50 DMA line ($71.50) following volume-driven losses. Reported Jul &#39;22 quarterly earnings +30% on +11% sales revenues versus the year ago period. Fundamental concerns remain as prior quarterly and annual earnings (C and A criteria) are not a match with the fact-based investment system&#39;s guidelines.<br><hr>9/6/2022 12:44:03 PM - Consolidating below its 50 DMA line following volume-driven losses last week. Reported Jul &#39;22 quarterly earnings +30% on +11% sales revenues versus the year ago period. Fundamental concerns remain as prior quarterly and annual earnings (C and A criteria) are not a match with the fact-based investment system&#39;s guidelines.<br><hr>9/28/2020 12:12:12 PM - Consolidating near prior highs and its 50 DMA line which define near-term support in the $68 area. Fundamental concerns remain as prior quarterly and annual earnings (C and A criteria) are not a match with the fact-based investment system&#39;s guidelines.<br><hr>